Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line

被引:211
|
作者
Essletzbichler, Patrick [1 ]
Konopka, Tomasz [2 ]
Santoro, Federica [1 ]
Chen, Doris [2 ]
Gapp, Bianca V. [2 ]
Kralovics, Robert [2 ]
Brummelkamp, Thijn R. [2 ,3 ]
Nijman, Sebastian M. B. [1 ,2 ]
Buerckstuemmer, Tilmann [1 ]
机构
[1] Haplogen GmbH, A-7030 Vienna, Austria
[2] Austrian Acad Sci CeMM, Res Ctr Mol Med, A-7090 Vienna, Austria
[3] Netherlands Canc Inst, NL-7066 CX Amsterdam, Netherlands
关键词
EMBRYONIC STEM-CELLS; CHROMOSOMAL DELETIONS; GENETIC SCREENS; CAS9; INVERSIONS; NUCLEASES; CRISPR-CAS9; DERIVATION; LEUKEMIA;
D O I
10.1101/gr.177220.114
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Near-haploid human cell lines are instrumental for genetic screens and genome engineering as gene inactivation is greatly facilitated by the absence of a second gene copy. However, no completely haploid human cell line has been described, hampering the genetic accessibility of a subset of genes. The near-haploid human cell line HAP1 contains a single copy of all chromosomes except for a heterozygous 30-megabase fragment of Chromosome 15. This large fragment encompasses 330 genes and is integrated on the long arm of Chromosome 19. Here, we employ a CRISPR/Cas9-based genome engineering strategy to excise this sizeable chromosomal fragment and to efficiently and reproducibly derive clones that retain their haploid state. Importantly, spectral karyotyping and single-nucleotide polymorphism (SNP) genotyping revealed that engineered-HAPloid (eHAP) cells are fully haploid with no gross chromosomal aberrations induced by Cas9. Furthermore, whole-genome sequence and transcriptome analysis of the parental HAP1 and an eHAP cell line showed that transcriptional changes are limited to the excised Chromosome 15 fragment. Together, we demonstrate the feasibility of efficiently engineering megabase deletions with the CRISPR/Cas9 technology and report the first fully haploid human cell line.
引用
收藏
页码:2059 / 2065
页数:7
相关论文
共 50 条
  • [21] CRISPR/Cas9 and Anther Culture for Precision Double Haploid Line Production in Controlled Environments
    Sharma, Avinash
    Pandey, Himanshu
    Misra, Varucha
    Kumar, Rajeev
    Vashishth, Amit
    Devadas, V. S.
    Mall, A. K.
    Ashutosh, Megha
    Raghvan, Megha
    Kesavan, Ajith Kumar
    Chaturvedi, Vishva Deepak
    PLANT BREEDING, 2024,
  • [22] G1 phase synchronization prevents ON-target megabase-scale rearrangements induced by CRISPR-Cas9
    Boutin, J.
    Fayet, S.
    Cullot, G.
    Prat, F.
    Bedel, A.
    Moreau-Gaudry, F.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A273 - A273
  • [23] Engineering Plant Immunity: Using CRISPR/Cas9 to Generate Virus Resistance
    Zaidi, Syed Shan-e-Ali
    Tashkandi, Menai
    Mansoor, Shahid
    Mahfouz, Magdy M.
    FRONTIERS IN PLANT SCIENCE, 2016, 7
  • [24] Optimized protocol to create deletion in adherent cell lines using CRISPR/Cas9 system
    Farooq, Umer
    Notani, Dimple
    STAR PROTOCOLS, 2021, 2 (04):
  • [25] Using CRISPR/Cas9 Technology to Generate a Non-Human Primate Model of Clonal Hematopoiesis
    Chen, Shirley
    Yu, Kyung-Rok
    Corat, Marcus
    Cordes, Stefan
    Shin, Tae-Hoon
    Aljanahi, Aisha
    Truitt, Lauren
    Metais, Jean-Yves
    Natanson, Hannah
    Donahue, Robert
    Dunbar, Cynthia
    MOLECULAR THERAPY, 2018, 26 (05) : 372 - 373
  • [26] Using CRISPR/Cas9 to generate isogenic cell lines and reference standards for applications in cancer diagnostics
    Jin, Huanyu
    Cheng, Xin
    Nga Nguyen
    Zheng, Qi
    Shi, Mi
    Hilmer, Andrew
    Yuan, Yuan
    Chen-Tsai, Ruby Yanru
    Kong, Ling-Jie
    CANCER RESEARCH, 2017, 77
  • [27] CRISPR-Cas9 globin editing can induce megabase-scale partial uniparental disomy with imprinting defects in hematopoietic cells
    Boutin, J.
    Rosier, J.
    Cappellen, D.
    Moreau-Gaudry, F.
    Bedel, A.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A12 - A13
  • [28] Generation of a FTO gene knockout human embryonic stem cell line using CRISPR/Cas9 editing
    Wei, Cong
    Luo, Qian
    Wang, Binsheng
    Long, Yan
    Zhang, Meng
    Shan, Wei
    Yu, Xiaohong
    Xu, Yulin
    Qian, Pengxu
    Huang, He
    STEM CELL RESEARCH, 2021, 53
  • [29] CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells
    J. Boutin
    J. Rosier
    D. Cappellen
    F. Prat
    J. Toutain
    P. Pennamen
    J. Bouron
    C. Rooryck
    J. P. Merlio
    I. Lamrissi-Garcia
    G. Cullot
    S. Amintas
    V. Guyonnet-Duperat
    C. Ged
    J. M. Blouin
    E. Richard
    S. Dabernat
    F. Moreau-Gaudry
    A. Bedel
    Nature Communications, 12
  • [30] Efficient deletion of microRNAs using CRISPR/Cas9 with dual guide RNAs
    Ijee, Smitha
    Chambayil, Karthik
    Chaudhury, Anurag Dutta
    Bagchi, Abhirup
    Modak, Kirti
    Das, Saswati
    Benjamin, Esther Sathya Bama
    Rani, Sonam
    Paul, Daniel Zechariah
    Nath, Aneesha
    Roy, Debanjan
    Palani, Dhavapriya
    Priyanka, Sweety
    Ravichandran, Rakshini
    Kumary, Betty K.
    Sivamani, Yazhini
    Vijayanand, S.
    Babu, Dinesh
    Nakamura, Yukio
    Thamodaran, Vasanth
    Balasubramanian, Poonkuzhali
    Velayudhan, Shaji R.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 10